Metraipolis › archive › dc_2d1bb49bc3da

Monoclonal antibodies in severe asthma: outcomes from real-world data — Europe PMC PMID:40873794

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40873794
DOI
10.3389/fmed.2025.1635688
License (as archived)
solo-consultazione
Archived
2026-11-10T17:09:43.275Z
SHA-256 of the archived text
e9fb2cb813fa84bddeaedc1c74591b83f0cdb7ead0ae05b14706b4581968611c
Stable URL of this page
https://metraipolis.com/documento/dc_2d1bb49bc3da

How to cite

Monoclonal antibodies in severe asthma: outcomes from real-world data — Europe PMC PMID:40873794 — Europe PMC (en), https://europepmc.org/article/MED/40873794 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d1bb49bc3da (Metraipolis archive dc_2d1bb49bc3da, sha256 e9fb2cb813fa84bddeaedc1c74591b83f0cdb7ead0ae05b14706b4581968611c)
BibTeX
@misc{dc2d1bb49bc3da,
  title = {Monoclonal antibodies in severe asthma: outcomes from real-world data — Europe PMC PMID:40873794},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40873794},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d1bb49bc3da; sha256 e9fb2cb813fa84bddeaedc1c74591b83f0cdb7ead0ae05b14706b4581968611c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40873794. Agents can read the archived copy with the MCP tool read_document.